CHI Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

CHI Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$14M	Buy	12,315,654 +11,559,916	+1,530%	+$62.6M	5.56%	5
2023 Q2	$3.94M	Sell	755,738 -30,000	-4%	-$153K	1.19%	15
2023 Q1	$4.22M	Sell	785,738 -13,002	-2%	-$70.7K	1.12%	14
2022 Q4	$2.96M	Hold	798,740	–	–	0.79%	15
2022 Q3	$3.99M	Buy	798,740 +267,965	+50%	+$1.49M	1.07%	17
2022 Q2	$3.1M	Hold	530,775	–	–	1.18%	17
2022 Q1	$3.78M	Sell	530,775 -114,211	-18%	-$1.12M	1.61%	15
2021 Q4	$8.51M	Buy	644,986 +236,789	+58%	+$3.92M	2.83%	11
2021 Q3	$9.39M	Hold	408,197	–	–	2.74%	11
2021 Q2	$17.9M	Buy	408,197 +3,000	+0.7%	+$167K	4.17%	7
2021 Q1	$29.4M	Buy	405,197 +112,078	+38%	+$7.96M	5.89%	5
2020 Q4	$12.7M	Hold	293,119	–	–	3.57%	9
2020 Q3	$12M	Hold	293,119	–	–	4.29%	8
2020 Q2	$17.6M	Sell	293,119 -3,108	-1%	-$285K	6.86%	6
2020 Q1	$22.3M	Buy	296,227 +378	+0.1%	+$43.5K	52.57%	1
2019 Q4	$40.7M	Sell	295,849 -3,172	-1%	-$386K	30.68%	2
2019 Q3	$35.5M	Buy	+299,021	New	+$41.7M	34.58%	2

Other funds holding ORTX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CHI Advisors's ORTX Position: Q3 2023 in Review

CHI Advisors increased its Orchard Therapeutics plc American Depositary Shares (ORTX) stake by 1,530% in Q3 2023, buying an estimated $62.6M and bringing the position to 12,315,654 shares worth $14M. The position accounts for 5.56% of the portfolio, ranked #5.

CHI Advisors first reported a position in ORTX in Q3 2019 and has held it in 17 quarters since. The position peaked at $40.7M in Q4 2019. 32 funds tracked by Wall St. Rank hold ORTX as of Q3 2023.

CHI Advisors held 12,315,654 shares of Orchard Therapeutics plc American Depositary Shares worth $14M as of Q3 2023.
CHI Advisors bought 11,559,916 Orchard Therapeutics plc American Depositary Shares shares in Q3 2023, an estimated $62.6M.
Orchard Therapeutics plc American Depositary Shares made up 5.56% of CHI Advisors's portfolio in Q3 2023, its #5 holding.
CHI Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2019 and has held it in 17 quarters since.
CHI Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $40.7M in Q4 2019.
32 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.